思创医惠
(300078)
| 流通市值：30.44亿 | | | 总市值：30.94亿 |
| 流通股本：11.07亿 | | | 总股本：11.25亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 564,563,042.63 | 396,895,157.25 | 198,888,851.7 | 1,005,929,309.42 |
| 营业收入 | 564,563,042.63 | 396,895,157.25 | 198,888,851.7 | 1,005,929,309.42 |
| 二、营业总成本 | 747,741,398.44 | 530,944,228.1 | 259,274,307.72 | 1,321,056,125.79 |
| 营业成本 | 471,373,535.14 | 335,860,863.4 | 161,518,898.57 | 794,313,517.55 |
| 税金及附加 | 14,958,529.25 | 4,542,938.14 | 1,002,478.25 | 16,653,098.3 |
| 销售费用 | 52,290,919.15 | 48,660,842.26 | 20,677,802.44 | 136,817,318.33 |
| 管理费用 | 82,581,715.07 | 45,768,251.89 | 27,062,599.15 | 136,553,336.83 |
| 研发费用 | 86,530,617.16 | 66,864,202.07 | 32,012,601.95 | 155,304,149.05 |
| 财务费用 | 40,006,082.67 | 29,247,130.34 | 16,999,927.36 | 81,414,705.73 |
| 其中:利息费用 | 46,822,650.08 | 34,038,652.73 | 17,815,505.02 | 89,619,299.72 |
| 其中:利息收入 | -3,375,849.8 | -2,749,816.37 | -1,165,922.93 | 5,577,931.16 |
| 加:公允价值变动收益 | 168,315 | 168,315 | 168,315 | -54,473,501.85 |
| 加:投资收益 | -1,229,128.03 | -2,438,636.97 | -2,298,946.65 | -12,090,218.19 |
| 资产处置收益 | -141,973.69 | -80,804.04 | -60,157.81 | 242,203.36 |
| 资产减值损失(新) | -60,761,811.29 | -59,473,641.62 | 278,200 | -270,512,452.64 |
| 信用减值损失(新) | -37,260,278.58 | -23,174,779.73 | -7,629,879.9 | -85,234,795.26 |
| 其他收益 | -880,360.81 | -3,864,045.1 | 1,830,833.99 | 20,347,339.03 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -283,283,593.21 | -222,912,663.31 | -68,097,091.39 | -716,848,241.92 |
| 加:营业外收入 | 918,847.89 | 351,944.22 | 351,916.22 | 1,408,630.67 |
| 减:营业外支出 | 487,299.63 | 441,742.63 | 476,864.51 | 91,924,003.54 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -282,852,044.95 | -223,002,461.72 | -68,222,039.68 | -807,363,614.79 |
| 减:所得税费用 | 2,866,789.49 | 2,667,338.08 | 354,853.52 | 68,112,332.86 |
| 六、净利润 | -285,718,834.44 | -225,669,799.8 | -68,576,893.2 | -875,475,947.65 |
| 持续经营净利润 | -285,718,834.44 | -225,669,799.8 | -68,576,893.2 | -871,424,582.28 |
| 终止经营净利润 | - | - | - | -4,051,365.37 |
| 归属于母公司股东的净利润 | -283,640,006.17 | -222,844,191.26 | -67,764,977.31 | -874,349,214.78 |
| 少数股东损益 | -2,078,828.27 | -2,825,608.54 | -811,915.89 | -1,126,732.87 |
| (一)基本每股收益 | -0.31 | -0.25 | -0.07 | -1.06 |
| (二)稀释每股收益 | -0.31 | -0.25 | -0.07 | -1.06 |
| 八、其他综合收益 | -3,120,519.31 | -894,702.86 | -407,982.75 | -11,021,940.25 |
| 归属于母公司股东的其他综合收益 | -3,143,007.24 | -828,834.68 | -111,997.56 | -11,167,162.86 |
| 九、综合收益总额 | -288,839,353.75 | -226,564,502.66 | -68,984,875.95 | -886,497,887.9 |
| 归属于母公司股东的综合收益总额 | -286,783,013.41 | -223,673,025.94 | -67,876,974.87 | -885,516,377.64 |
| 归属于少数股东的综合收益总额 | -2,056,340.34 | -2,891,476.72 | -1,107,901.08 | -981,510.26 |
| 公告日期 | 2024-10-30 | 2024-08-28 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 保留意见 |